TSNAD: an integrated software for cancer somatic mutation and tumour-specific neoantigen detection

Abstract excerpt

Tumour antigens have attracted much attention because of their importance to cancer diagnosis, prognosis and targeted therapy. With the development of cancer genomics, the identification of tumour-specific neoantigens became possible, which is a crucial step for cancer immunotherapy. In this study, we developed software called the tumour-specific neoantigen detector for detecting cancer somatic mutations...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Genomics and Diagnostics
• Share to Immunotherapy and Immune Responses
• Share to Monoclonal and Polyclonal Antibodies Research